Loading...

William J Murphy

Title(s)Professor, Dermatology
SchoolUniversity of California, Davis
Phone916-703-9397
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Immunoregulatory and effector roles of natural killer cell subsets
    NIH/NHLBI R01HL140921Jan 1, 2018 - Dec 31, 2021
    Role: Principal Investigator
    Multispecies Comparison of the Impact of Obesity on GVHD/GVT
    NIH/NCI R01CA214048Jan 12, 2017 - Dec 31, 2021
    Role: Principal Investigator
    1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
    NIH/NCI R01CA195904May 15, 2015 - Apr 30, 2018
    Role: Principal Investigator
    Radio-immunotherapy to Target Cancer Stem Cells in Solid Tumor Malignancies
    NIH/NCI R01CA189209Mar 6, 2015 - Feb 29, 2020
    Role: Principal Investigator
    Positive and Negative Regulation of Natural Killer Cells After BMT
    NIH/NHLBI R01HL089905Jul 18, 2007 - Nov 30, 2015
    Role: Principal Investigator
    Neuroendocrine Hormones to Promote Immune Reconstitution
    NIH/NIA R01AG022661Aug 1, 2003 - Jul 31, 2009
    Role: Principal Investigator
    Molecular targeting agents in GVHD/GVT: Role of cytokines and T cell subsets
    NIH/NCI R01CA102282Jul 1, 2003 - Apr 30, 2014
    Role: Principal Investigator
    Immunotherapy by CD40 stimulation and IL-2 against Cancer
    NIH/NCI R01CA095572Sep 1, 2002 - Jan 31, 2018
    Role: Principal Investigator
    Immunotherapy using NK cells to promote engraftment
    NIH/NCI R01CA093527Sep 1, 2002 - Aug 31, 2007
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Alvarez M, Simonetta F, Baker J, Pierini A, Wenokur AS, Morrison AR, Murphy WJ, Negrin RS. Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway. JCI Insight. 2019 Jun 18; 5. PMID: 31211693.
      View in: PubMed
    2. Murphy WJ, Longo DL. The Surprisingly Positive Association Between Obesity and Cancer Immunotherapy Efficacy. JAMA. 2019 Mar 18. PMID: 30882850.
      View in: PubMed
    3. Thangavelu G, Lee YC, Loschi M, Schaechter KM, Feser CJ, Koehn BH, Nowak EC, Zeiser R, Serody JS, Murphy WJ, Munn DH, Chambon P, Noelle RJ, Blazar BR. Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality. J Immunol. 2019 May 01; 202(9):2795-2805. PMID: 30885956.
      View in: PubMed
    4. Paz K, Flynn R, Du J, Tannheimer S, Johnson AJ, Dong S, Stark AK, Okkenhaug K, Panoskaltsis-Mortari A, Sage PT, Sharpe AH, Luznik L, Ritz J, Soiffer RJ, Cutler CS, Koreth J, Antin JH, Miklos DB, MacDonald KP, Hill GR, Maillard I, Serody JS, Murphy WJ, Munn DH, Feser C, Zaiken M, Vanhaesebroeck B, Turka LA, Byrd JC, Blazar BR. Targeting PI3Kd function for amelioration of murine chronic graft-versus-host disease. Am J Transplant. 2019 Feb 12. PMID: 30748099.
      View in: PubMed
    5. Withers SS, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Burton JH, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB. Metastatic immune infiltrates correlate with those of the primary tumour in canine osteosarcoma. Vet Comp Oncol. 2019 Jan 25. PMID: 30684301.
      View in: PubMed
    6. Luna JI, Grossenbacher SK, Sturgill IR, Ames E, Judge SJ, Bouzid LA, Darrow MA, Murphy WJ, Canter RJ. Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells. Cancers (Basel). 2019 Jan 14; 11(1). PMID: 30646520.
      View in: PubMed
    7. Wang Z, Monjazeb AM, Murphy WJ. The complicated effects of  obesity on cancer and immunotherapy. Immunotherapy. 2019 Jan; 11(1):11-14. PMID: 30702013.
      View in: PubMed
    8. Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR, Grossenbacher SK, Withers SS, Rebhun RB, Hartigan-O'Connor DJ, Méndez-Lagares G, Tarantal AF, Isseroff RR, Griffith TS, Schalper KA, Merleev A, Saha A, Maverakis E, Kelly K, Aljumaily R, Ibrahimi S, Mukherjee S, Machiorlatti M, Vesely SK, Longo DL, Blazar BR, Canter RJ, Murphy WJ, Monjazeb AM. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med. 2019 Jan; 25(1):141-151. PMID: 30420753.
      View in: PubMed
    9. Paz K, Flynn R, Du J, Qi J, Luznik L, Maillard I, MacDonald KP, Hill GR, Serody JS, Murphy WJ, Sage PT, Sharpe AH, Miklos D, Cutler CS, Koreth J, Antin JH, Soiffer RJ, Ritz J, Bradner JE, Melnick AM, Blazar BR. Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease. Blood. 2019 Jan 03; 133(1):94-99. PMID: 30279226.
      View in: PubMed
    10. Withers SS, Skorupski KA, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Rodriguez CO, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB. Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma. Vet Comp Oncol. 2019 Mar; 17(1):49-60. PMID: 30156029.
      View in: PubMed
    11. Dunai C, Murphy WJ. NK cells for PD-1/PD-L1 blockade immunotherapy: pinning down the NK cell. J Clin Invest. 2018 Oct 01; 128(10):4251-4253. PMID: 30198909.
      View in: PubMed
    12. Canter RJ, Murphy WJ. A possible new pathway in natural killer cell activation also reveals the difficulty in determining human NK cell function in cancer. J Immunother Cancer. 2018 Aug 07; 6(1):79. PMID: 30086799.
      View in: PubMed
    13. Chavez M, Silvestrini MT, Ingham ES, Fite BZ, Mahakian LM, Tam SM, Ilovitsh A, Monjazeb AM, Murphy WJ, Hubbard NE, Davis RR, Tepper CG, Borowsky AD, Ferrara KW. Distinct immune signatures in directly treated and distant tumors result from TLR adjuvants and focal ablation. Theranostics. 2018; 8(13):3611-3628. PMID: 30026870.
      View in: PubMed
    14. Withers SS, Moore PF, Chang H, Choi JW, McSorley SJ, Kent MS, Monjazeb AM, Canter RJ, Murphy WJ, Sparger EE, Rebhun RB. Multi-color flow cytometry for evaluating age-related changes in memory lymphocyte subsets in dogs. Dev Comp Immunol. 2018 10; 87:64-74. PMID: 29859828.
      View in: PubMed
    15. Canter RJ, Le CT, Beerthuijzen JMT, Murphy WJ. Obesity as an immune-modifying factor in cancer immunotherapy. J Leukoc Biol. 2018 Sep; 104(3):487-497. PMID: 29762866.
      View in: PubMed
    16. McGee HM, Daly ME, Azghadi S, Stewart SL, Oesterich L, Schlom J, Donahue R, Schoenfeld JD, Chen Q, Rao S, Fragoso RC, Valicenti RK, Canter RJ, Maverakis EM, Murphy WJ, Kelly K, Monjazeb AM. Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. Int J Radiat Oncol Biol Phys. 2018 Aug 01; 101(5):1259-1270. PMID: 29891204.
      View in: PubMed
    17. Kiuru M, Tartar DM, Qi L, Chen D, Yu L, Konia T, McPherson JD, Murphy WJ, Fung MA. Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features. J Am Acad Dermatol. 2018 Aug; 79(2):221-229. PMID: 29653212.
      View in: PubMed
    18. Aguilar EG, Murphy WJ. Obesity induced T cell dysfunction and implications for cancer immunotherapy. Curr Opin Immunol. 2018 04; 51:181-186. PMID: 29655021.
      View in: PubMed
    19. Liu Z, Liu H, Shi M, Ahmed HAW, Huo L, Zhang Y, Kong D, Wen M, Wang F, Chen M, Murphy WJ, Sun K. Donor HSCs with a preexisting ASXL1-mutation led to the development of FLT3-ITD positive AML in the donor and FLT3-ITD negative AML in the recipient after unrelated transplant. Bone Marrow Transplant. 2018 04; 53(4):499-502. PMID: 29330388.
      View in: PubMed
    20. Murphy WJ. Making a Better Hematopoietic Stem Cell - Timing Is Everything. N Engl J Med. 2018 01 04; 378(1):89-91. PMID: 29298159.
      View in: PubMed
    21. Henderson T, Chen M, Darrow MA, Li CS, Chiu CL, Monjazeb AM, Murphy WJ, Canter RJ. Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas. J Surg Res. 2018 03; 223:207-214. PMID: 29433875.
      View in: PubMed
    22. Canter RJ, Grossenbacher SK, Foltz JA, Sturgill IR, Park JS, Luna JI, Kent MS, Culp WTN, Chen M, Modiano JF, Monjazeb AM, Lee DA, Murphy WJ. Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial. J Immunother Cancer. 2017 Dec 19; 5(1):98. PMID: 29254507.
      View in: PubMed
    23. Janecka JE, Zhang Y, Li D, Munkhtsog B, Bayaraa M, Galsandorj N, Wangchuk TR, Karmacharya D, Li J, Lu Z, Uulu KZ, Gaur A, Kumar S, Kumar K, Hussain S, Muhammad G, Jevit M, Hacker C, Burger P, Wultsch C, Janecka MJ, Helgen K, Murphy WJ, Jackson R. Range-Wide Snow Leopard Phylogeography Supports Three Subspecies. J Hered. 2017 Sep 01; 108(6):597-607. PMID: 28498961.
      View in: PubMed
    24. Jena PK, Sheng L, Liu HX, Kalanetra KM, Mirsoian A, Murphy WJ, French SW, Krishnan VV, Mills DA, Wan YY. Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment. Am J Pathol. 2017 Aug; 187(8):1800-1813. PMID: 28711154.
      View in: PubMed
    25. Arzi B, Clark KC, Sundaram A, Spriet M, Verstraete FJM, Walker NJ, Loscar MR, Fazel N, Murphy WJ, Vapniarsky N, Borjesson DL. Therapeutic Efficacy of Fresh, Allogeneic Mesenchymal Stem Cells for Severe Refractory Feline Chronic Gingivostomatitis. Stem Cells Transl Med. 2017 Aug; 6(8):1710-1722. PMID: 28618186.
      View in: PubMed
    26. Zamora AE, Aguilar EG, Sungur CM, Khuat LT, Dunai C, Lochhead GR, Du J, Pomeroy C, Blazar BR, Longo DL, Venstrom JM, Baumgarth N, Murphy WJ. Licensing delineates helper and effector NK cell subsets during viral infection. JCI Insight. 2017 May 18; 2(10). PMID: 28515356.
      View in: PubMed
    27. Grossenbacher SK, Aguilar EG, Murphy WJ. Leveraging natural killer cells for cancer immunotherapy. Immunotherapy. 2017 05; 9(6):487-497. PMID: 28472904.
      View in: PubMed
    28. Baird JR, Monjazeb AM, Shah O, McGee H, Murphy WJ, Crittenden MR, Gough MJ. Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control. Int J Radiat Oncol Biol Phys. 2017 10 01; 99(2):362-373. PMID: 28871985.
      View in: PubMed
    29. Sckisel GD, Mirsoian A, Minnar CM, Crittenden M, Curti B, Chen JQ, Blazar BR, Borowsky AD, Monjazeb AM, Murphy WJ. Differential phenotypes of memory CD4 and CD8 T cells in the spleen and peripheral tissues following immunostimulatory therapy. J Immunother Cancer. 2017; 5:33. PMID: 28428882.
      View in: PubMed
    30. Silvestrini MT, Ingham ES, Mahakian LM, Kheirolomoom A, Liu Y, Fite BZ, Tam SM, Tucci ST, Watson KD, Wong AW, Monjazeb AM, Hubbard NE, Murphy WJ, Borowsky AD, Ferrara KW. Priming is key to effective incorporation of image-guided thermal ablation into immunotherapy protocols. JCI Insight. 2017 Mar 23; 2(6):e90521. PMID: 28352658.
      View in: PubMed
    31. Clark KC, Fierro FA, Ko EM, Walker NJ, Arzi B, Tepper CG, Dahlenburg H, Cicchetto A, Kol A, Marsh L, Murphy WJ, Fazel N, Borjesson DL. Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome. Stem Cell Res Ther. 2017 03 20; 8(1):69. PMID: 28320483.
      View in: PubMed
    32. Tietze JK, Angelova D, Heppt MV, Reinholz M, Murphy WJ, Spannagl M, Ruzicka T, Berking C. The proportion of circulating CD45RO+CD8+ memory T cells is correlated with clinical response in melanoma patients treated with ipilimumab. Eur J Cancer. 2017 04; 75:268-279. PMID: 28242504.
      View in: PubMed
    33. Luna JI, Grossenbacher SK, Murphy WJ, Canter RJ. Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy. Expert Opin Biol Ther. 2017 03; 17(3):313-324. PMID: 27960589.
      View in: PubMed
    34. Park JS, Withers SS, Modiano JF, Kent MS, Chen M, Luna JI, Culp WTN, Sparger EE, Rebhun RB, Monjazeb AM, Murphy WJ, Canter RJ. Canine cancer immunotherapy studies: linking mouse and human. J Immunother Cancer. 2016; 4:97. PMID: 28031824.
      View in: PubMed
    35. Murphy WJ. Being "penny-wise but pound foolish" in cancer immunotherapy research: the urgent need for mouse cancer models to reflect human modifying factors. J Immunother Cancer. 2016; 4:88. PMID: 28031818.
      View in: PubMed
    36. Pai CS, Khuat LT, Chen M, Murphy WJ, Abedi M. Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice. Biol Blood Marrow Transplant. 2017 01; 23(1):30-37. PMID: 27815049.
      View in: PubMed
    37. Minnar CM, Murphy WJ. Immunoregulatory pathways following strong inflammatory processes markedly impair CD4+ T cell responses. Hum Vaccin Immunother. 2016 09; 12(9):2249-52. PMID: 27409155.
      View in: PubMed
    38. McDonald-Hyman C, Flynn R, Panoskaltsis-Mortari A, Peterson N, MacDonald KP, Hill GR, Luznik L, Serody JS, Murphy WJ, Maillard I, Munn DH, Turka LA, Koreth J, Cutler CS, Soiffer RJ, Antin JH, Ritz J, Blazar BR. Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner. Blood. 2016 08 18; 128(7):1013-7. PMID: 27385791.
      View in: PubMed
    39. Saha A, O'Connor RS, Thangavelu G, Lovitch SB, Dandamudi DB, Wilson CB, Vincent BG, Tkachev V, Pawlicki JM, Furlan SN, Kean LS, Aoyama K, Taylor PA, Panoskaltsis-Mortari A, Foncea R, Ranganathan P, Devine SM, Burrill JS, Guo L, Sacristan C, Snyder NW, Blair IA, Milone MC, Dustin ML, Riley JL, Bernlohr DA, Murphy WJ, Fife BT, Munn DH, Miller JS, Serody JS, Freeman GJ, Sharpe AH, Turka LA, Blazar BR. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016 07 01; 126(7):2642-60. PMID: 27294527.
      View in: PubMed
    40. Mamalis A, Koo E, Garcha M, Murphy WJ, Isseroff RR, Jagdeo J. High fluence light emitting diode-generated red light modulates characteristics associated with skin fibrosis. J Biophotonics. 2016 12; 9(11-12):1167-1179. PMID: 27174640.
      View in: PubMed
    41. Grossenbacher SK, Canter RJ, Murphy WJ. Natural killer cell immunotherapy to target stem-like tumor cells. J Immunother Cancer. 2016; 4:19. PMID: 27096096.
      View in: PubMed
    42. Canter RJ, Grossenbacher SK, Ames E, Murphy WJ. Immune targeting of cancer stem cells in gastrointestinal oncology. J Gastrointest Oncol. 2016 Apr; 7(Suppl 1):S1-S10. PMID: 27034806.
      View in: PubMed
    43. Flynn R, Paz K, Du J, Reichenbach DK, Taylor PA, Panoskaltsis-Mortari A, Vulic A, Luznik L, MacDonald KK, Hill GR, Nyuydzefe MS, Weiss JM, Chen W, Trzeciak A, Serody JS, Aguilar EG, Murphy WJ, Maillard I, Munn D, Koreth J, Cutler CS, Antin JH, Ritz J, Waksal SD, Zanin-Zhorov A, Blazar BR. Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism. Blood. 2016 04 28; 127(17):2144-54. PMID: 26983850.
      View in: PubMed
    44. Monjazeb AM, Kent MS, Grossenbacher SK, Mall C, Zamora AE, Mirsoian A, Chen M, Kol A, Shiao SL, Reddy A, Perks JR, T N Culp W, Sparger EE, Canter RJ, Sckisel GD, Murphy WJ. Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies. Clin Cancer Res. 2016 Sep 01; 22(17):4328-40. PMID: 26979392; PMCID: PMC5010514 [Available on 09/01/17].
    45. Alvarez M, Sun K, Murphy WJ. Mouse host unlicensed NK cells promote donor allogeneic bone marrow engraftment. Blood. 2016 Mar 03; 127(9):1202-5. PMID: 26738538; PMCID: PMC4778165.
    46. Stolfi JL, Pai CC, Murphy WJ. Preclinical modeling of hematopoietic stem cell transplantation - advantages and limitations. FEBS J. 2016 05; 283(9):1595-606. PMID: 26640088.
      View in: PubMed
    47. Arzi B, Mills-Ko E, Verstraete FJ, Kol A, Walker NJ, Badgley MR, Fazel N, Murphy WJ, Vapniarsky N, Borjesson DL. Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats. Stem Cells Transl Med. 2016 Jan; 5(1):75-86. PMID: 26582907.
      View in: PubMed
    48. Kheirolomoom A, Ingham ES, Mahakian LM, Tam SM, Silvestrini MT, Tumbale SK, Foiret J, Hubbard NE, Borowsky AD, Murphy WJ, Ferrara KW. CpG expedites regression of local and systemic tumors when combined with activatable nanodelivery. J Control Release. 2015 Dec 28; 220(Pt A):253-264. PMID: 26471394; PMCID: PMC4688109 [Available on 12/28/16].
    49. Shanker A, Pellom ST, Dudimah DF, Thounaojam MC, de Kluyver RL, Brooks AD, Yagita H, McVicar DW, Murphy WJ, Longo DL, Sayers TJ. Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity. Cancer Res. 2015 Dec 15; 75(24):5260-72. PMID: 26494122.
      View in: PubMed
    50. Mamalis A, Koo E, Isseroff RR, Murphy W, Jagdeo J. Resveratrol Prevents High Fluence Red Light-Emitting Diode Reactive Oxygen Species-Mediated Photoinhibition of Human Skin Fibroblast Migration. PLoS One. 2015; 10(10):e0140628. PMID: 26488596; PMCID: PMC4619307.
    51. Sckisel GD, Mirsoian A, Bouchlaka MN, Tietze JK, Chen M, Blazar BR, Murphy WJ. Late administration of murine CTLA-4 blockade prolongs CD8-mediated anti-tumor effects following stimulatory cancer immunotherapy. Cancer Immunol Immunother. 2015 Dec; 64(12):1541-52. PMID: 26423422; PMCID: PMC4782757.
    52. Yokdang N, Hatakeyama J, Wald JH, Simion C, Tellez JD, Chang DZ, Swamynathan MM, Chen M, Murphy WJ, Carraway Iii KL, Sweeney C. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. 2016 06 02; 35(22):2932-47. PMID: 26387542.
      View in: PubMed
    53. Ames E, Canter RJ, Grossenbacher SK, Mac S, Chen M, Smith RC, Hagino T, Perez-Cunningham J, Sckisel GD, Urayama S, Monjazeb AM, Fragoso RC, Sayers TJ, Murphy WJ. NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype. J Immunol. 2015 Oct 15; 195(8):4010-9. PMID: 26363055; PMCID: PMC4781667 [Available on 10/15/16].
    54. Mall C, Sckisel GD, Proia DA, Mirsoian A, Grossenbacher SK, Pai CS, Chen M, Monjazeb AM, Kelly K, Blazar BR, Murphy WJ. Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer. Oncoimmunology. 2016 Feb; 5(2):e1075114. PMID: 27057446.
      View in: PubMed
    55. Koehn BH, Apostolova P, Haverkamp JM, Miller JS, McCullar V, Tolar J, Munn DH, Murphy WJ, Brickey WJ, Serody JS, Gabrilovich DI, Bronte V, Murray PJ, Ting JP, Zeiser R, Blazar BR. GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells. Blood. 2015 Sep 24; 126(13):1621-8. PMID: 26265697.
      View in: PubMed
    56. Zamora AE, Grossenbacher SK, Aguilar EG, Murphy WJ. Models to Study NK Cell Biology and Possible Clinical Application. Curr Protoc Immunol. 2015 Aug 03; 110:14.37.1-14. PMID: 26237009.
      View in: PubMed
    57. Sckisel GD, Bouchlaka MN, Monjazeb AM, Crittenden M, Curti BD, Wilkins DE, Alderson KA, Sungur CM, Ames E, Mirsoian A, Reddy A, Alexander W, Soulika A, Blazar BR, Longo DL, Wiltrout RH, Murphy WJ. Out-of-Sequence Signal 3 Paralyzes Primary CD4(+) T-Cell-Dependent Immunity. Immunity. 2015 Aug 18; 43(2):240-50. PMID: 26231116; PMCID: PMC4770886.
    58. Ames E, Canter RJ, Grossenbacher SK, Mac S, Smith RC, Monjazeb AM, Chen M, Murphy WJ. Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells. Oncoimmunology. 2015 Sep; 4(9):e1036212. PMID: 26405602.
      View in: PubMed
    59. Flynn R, Allen JL, Luznik L, MacDonald KP, Paz K, Alexander KA, Vulic A, Du J, Panoskaltsis-Mortari A, Taylor PA, Poe JC, Serody JS, Murphy WJ, Hill GR, Maillard I, Koreth J, Cutler CS, Soiffer RJ, Antin JH, Ritz J, Chao NJ, Clynes RA, Sarantopoulos S, Blazar BR. Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease. Blood. 2015 Jun 25; 125(26):4085-94. PMID: 25852057.
      View in: PubMed
    60. Erdembileg A, Mirsoian A, Enkhmaa B, Zhang W, Beckett LA, Murphy WJ, Berglund LF. Attenuated age-impact on systemic inflammatory markers in the presence of a metabolic burden. PLoS One. 2015; 10(3):e0121947. PMID: 25815855; PMCID: PMC4376898.
    61. Veenstra RG, Flynn R, Kreymborg K, McDonald-Hyman C, Saha A, Taylor PA, Osborn MJ, Panoskaltsis-Mortari A, Schmitt-Graeff A, Lieberknect E, Murphy WJ, Serody JS, Munn DH, Freeman GJ, Allison JP, Mak TW, van den Brink M, Zeiser R, Blazar BR. B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality. Blood. 2015 May 21; 125(21):3335-46. PMID: 25814530.
      View in: PubMed
    62. Boeckh M, Murphy WJ, Peggs KS. Reprint of: Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies. Biol Blood Marrow Transplant. 2015 Feb; 21(2 Suppl):S19-24. PMID: 25620648.
      View in: PubMed
    63. Mirsoian A, Murphy WJ. Obesity and cancer immunotherapy toxicity. Immunotherapy. 2015; 7(4):319-22. PMID: 25917623.
      View in: PubMed
    64. Boeckh M, Murphy WJ, Peggs KS. Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies. Biol Blood Marrow Transplant. 2015 Jan; 21(1):24-9. PMID: 25452035.
      View in: PubMed
    65. Mirsoian A, Bouchlaka MN, Sckisel GD, Chen M, Pai CC, Maverakis E, Spencer RG, Fishbein KW, Siddiqui S, Monjazeb AM, Martin B, Maudsley S, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Taub DD, Murphy WJ. Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice. J Exp Med. 2014 Nov 17; 211(12):2373-83. PMID: 25366964; PMCID: PMC4235633.
    66. Canter RJ, Ames E, Mac S, Grossenbacher SK, Chen M, Li CS, Borys D, Smith RC, Tellez J, Sayers TJ, Monjazeb AM, Murphy WJ. Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma. BMC Cancer. 2014 Oct 10; 14:756. PMID: 25301268; PMCID: PMC4200119.
    67. Dubovsky JA, Flynn R, Du J, Harrington BK, Zhong Y, Kaffenberger B, Yang C, Towns WH, Lehman A, Johnson AJ, Muthusamy N, Devine SM, Jaglowski S, Serody JS, Murphy WJ, Munn DH, Luznik L, Hill GR, Wong HK, MacDonald KK, Maillard I, Koreth J, Elias L, Cutler C, Soiffer RJ, Antin JH, Ritz J, Panoskaltsis-Mortari A, Byrd JC, Blazar BR. Ibrutinib treatment ameliorates murine chronic graft-versus-host disease. J Clin Invest. 2014 Nov; 124(11):4867-76. PMID: 25271622.
      View in: PubMed
    68. Murphy WJ. Bringing out the DCs' softer side in GVHD. Blood. 2014 Sep 18; 124(12):1852-3. PMID: 25606629.
      View in: PubMed
    69. Ames E, Murphy WJ. The authors' reply. Transplantation. 2014 Sep 15; 98(5):e39-40. PMID: 25171530.
      View in: PubMed
    70. Steiber AL, León JB, Hand RK, Murphy WJ, Fouque D, Parrott JS, Kalantar-Zadeh K, Cuppari L. Using a web-based nutrition algorithm in hemodialysis patients. J Ren Nutr. 2015 Jan; 25(1):6-16. PMID: 25193109.
      View in: PubMed
    71. Monjazeb AM, Tietze JK, Grossenbacher SK, Hsiao HH, Zamora AE, Mirsoian A, Koehn B, Blazar BR, Weiss JM, Wiltrout RH, Sckisel GD, Murphy WJ. Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help. PLoS One. 2014; 9(8):e102709. PMID: 25119341; PMCID: PMC4131875.
    72. Pai CC, Hsiao HH, Sun K, Chen M, Hagino T, Tellez J, Mall C, Blazar BR, Monjazeb A, Abedi M, Murphy WJ. Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels. Biol Blood Marrow Transplant. 2014 Dec; 20(12):1899-904. PMID: 25064746; PMCID: PMC4254314.
    73. Pai CC, Chen M, Mirsoian A, Grossenbacher SK, Tellez J, Ames E, Sun K, Jagdeo J, Blazar BR, Murphy WJ, Abedi M. Treatment of chronic graft-versus-host disease with bortezomib. Blood. 2014 Sep 04; 124(10):1677-88. PMID: 25009225; PMCID: PMC4155274.
    74. Alvarez M, Bouchlaka MN, Sckisel GD, Sungur CM, Chen M, Murphy WJ. Increased antitumor effects using IL-2 with anti-TGF-ß reveals competition between mouse NK and CD8 T cells. J Immunol. 2014 Aug 15; 193(4):1709-16. PMID: 25000978; PMCID: PMC4241855.
    75. Perez-Cunningham J, Ames E, Smith RC, Peter AK, Naidu R, Nolta JA, Murphy WJ. Natural killer cell subsets differentially reject embryonic stem cells based on licensing. Transplantation. 2014 May 27; 97(10):992-8. PMID: 24704665.
      View in: PubMed
    76. Flynn R, Du J, Veenstra RG, Reichenbach DK, Panoskaltsis-Mortari A, Taylor PA, Freeman GJ, Serody JS, Murphy WJ, Munn DH, Sarantopoulos S, Luznik L, Maillard I, Koreth J, Cutler C, Soiffer RJ, Antin JH, Ritz J, Dubovsky JA, Byrd JC, MacDonald KP, Hill GR, Blazar BR. Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans. Blood. 2014 Jun 19; 123(25):3988-98. PMID: 24820310.
      View in: PubMed
    77. Weiss JM, Subleski JJ, Back T, Chen X, Watkins SK, Yagita H, Sayers TJ, Murphy WJ, Wiltrout RH. Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/aCD40 therapy. J Immunol. 2014 Jun 15; 192(12):5821-9. PMID: 24808361.
      View in: PubMed
    78. Sckisel GD, Tietze JK, Zamora AE, Hsiao HH, Priest SO, Wilkins DE, Lanier LL, Blazar BR, Baumgarth N, Murphy WJ. Influenza infection results in local expansion of memory CD8(+) T cells with antigen non-specific phenotype and function. Clin Exp Immunol. 2014 Jan; 175(1):79-91. PMID: 23937663; PMCID: PMC3898557.
    79. Sungur CM, Murphy WJ. Positive and negative regulation by NK cells in cancer. Crit Rev Oncog. 2014; 19(1-2):57-66. PMID: 24941373.
      View in: PubMed
    80. Bouchlaka MN, Murphy WJ. Impact of aging in cancer immunotherapy: The importance of using accurate preclinical models. Oncoimmunology. 2013 Dec 01; 2(12):e27186. PMID: 24498569.
      View in: PubMed
    81. Shurin MR, Umansky V, Malyguine A, Hurwitz AA, Apte RN, Whiteside T, Jewett A, Thanavala Y, Murphy WJ. Cellular and molecular pathways in the tumor immunoenvironment: 3rd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, 22-25 April 2013, Krakow, Poland. Cancer Immunol Immunother. 2014 Jan; 63(1):73-80. PMID: 24271210.
      View in: PubMed
    82. Bouchlaka MN, Sckisel GD, Chen M, Mirsoian A, Zamora AE, Maverakis E, Wilkins DE, Alderson KL, Hsiao HH, Weiss JM, Monjazeb AM, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Redelman D, Taub DD, Murphy WJ. Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. J Exp Med. 2013 Oct 21; 210(11):2223-37. PMID: 24081947.
      View in: PubMed
    83. Abedi M, Murphy WJ. The path(way) less traveled. Blood. 2013 Sep 19; 122(12):1996-7. PMID: 24052539.
      View in: PubMed
    84. Saha A, Aoyama K, Taylor PA, Koehn BH, Veenstra RG, Panoskaltsis-Mortari A, Munn DH, Murphy WJ, Azuma M, Yagita H, Fife BT, Sayegh MH, Najafian N, Socie G, Ahmed R, Freeman GJ, Sharpe AH, Blazar BR. Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality. Blood. 2013 Oct 24; 122(17):3062-73. PMID: 24030385.
      View in: PubMed
    85. Ames E, Murphy WJ. Advantages and clinical applications of natural killer cells in cancer immunotherapy. Cancer Immunol Immunother. 2014 Jan; 63(1):21-8. PMID: 23989217.
      View in: PubMed
    86. Barao I, Wright PW, Sungur CM, Anderson SK, Redelman D, Murphy WJ. Differential expression of the Ly49G(B6), but not the Ly49G(BALB), receptor isoform during natural killer cell reconstitution after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013 Oct; 19(10):1446-52. PMID: 23911940.
      View in: PubMed
    87. Monjazeb AM, Zamora AE, Grossenbacher SK, Mirsoian A, Sckisel GD, Murphy WJ. Immunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapies. Front Oncol. 2013; 3:197. PMID: 23898464; PMCID: PMC3724213.
    88. Sungur CM, Tang-Feldman YJ, Zamora AE, Alvarez M, Pomeroy C, Murphy WJ. Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses. Blood. 2013 Aug 22; 122(8):1518-21. PMID: 23818546.
      View in: PubMed
    89. He W, Luo J, Bourguet F, Xing L, Yi SK, Gao T, Blanchette C, Henderson PT, Kuhn E, Malfatti M, Murphy WJ, Cheng RH, Lam KS, Coleman MA. Controlling the diameter, monodispersity, and solubility of ApoA1 nanolipoprotein particles using telodendrimer chemistry. Protein Sci. 2013 Aug; 22(8):1078-86. PMID: 23754445; PMCID: PMC3832044.
    90. Aoyama K, Saha A, Tolar J, Riddle MJ, Veenstra RG, Taylor PA, Blomhoff R, Panoskaltsis-Mortari A, Klebanoff CA, Socié G, Munn DH, Murphy WJ, Serody JS, Fulton LM, Teshima T, Chandraratna RA, Dmitrovsky E, Guo Y, Noelle RJ, Blazar BR. Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration. Blood. 2013 Sep 19; 122(12):2125-34. PMID: 23814022.
      View in: PubMed
    91. Alvarez M, Sungur CM, Ames E, Anderson SK, Pomeroy C, Murphy WJ. Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance. J Immunol. 2013 Jul 15; 191(2):688-98. PMID: 23752612.
      View in: PubMed
    92. Murphy WJ. Of mice and men. Biol Blood Marrow Transplant. 2013 Aug; 19(8):1140-1. PMID: 23680473.
      View in: PubMed
    93. Sungur CM, Tang-Feldman YJ, Ames E, Alvarez M, Chen M, Longo DL, Pomeroy C, Murphy WJ. Murine natural killer cell licensing and regulation by T regulatory cells in viral responses. Proc Natl Acad Sci U S A. 2013 Apr 30; 110(18):7401-6. PMID: 23589894.
      View in: PubMed
    94. Sungur CM, Murphy WJ. Utilization of mouse models to decipher natural killer cell biology and potential clinical applications. Hematology Am Soc Hematol Educ Program. 2013; 2013:227-33. PMID: 24319185.
      View in: PubMed
    95. Bouchlaka MN, Sckisel GD, Wilkins D, Maverakis E, Monjazeb AM, Fung M, Welniak L, Redelman D, Fuchs A, Evrensel CA, Murphy WJ. Mechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responses. PLoS One. 2012; 7(10):e48049. PMID: 23133545; PMCID: PMC3485005.
    96. Sckisel GD, Murphy WJ. Specificity may be overrated in cancer immunotherapy: Getting to know the nonspecific side of memory T Cells. Oncoimmunology. 2012 Oct 01; 1(7):1208-1210. PMID: 23170282.
      View in: PubMed
    97. Sun K, Hsiao HH, Li M, Ames E, Bouchlaka M, Welniak LA, Hagino T, Jagdeo J, Pai CC, Chen M, Blazar BR, Abedi M, Murphy WJ. IFN-? receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation. J Immunol. 2012 Aug 15; 189(4):2033-42. PMID: 22778394; PMCID: PMC3509544.
    98. Monjazeb AM, Hsiao HH, Sckisel GD, Murphy WJ. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer. J Immunotoxicol. 2012 Jul-Sep; 9(3):248-58. PMID: 22734880.
      View in: PubMed
    99. Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol. 2012 May 11; 12(6):443-58. PMID: 22576252; PMCID: PMC3552454.
    100. Murphy WJ, Nolta JA. Autoimmune T cells lured to a FASL web of death by MSCs. Cell Stem Cell. 2012 May 04; 10(5):485-7. PMID: 22560070.
      View in: PubMed
    101. Tietze JK, Wilkins DE, Sckisel GD, Bouchlaka MN, Alderson KL, Weiss JM, Ames E, Bruhn KW, Craft N, Wiltrout RH, Longo DL, Lanier LL, Blazar BR, Redelman D, Murphy WJ. Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy. Blood. 2012 Mar 29; 119(13):3073-83. PMID: 22251483; PMCID: PMC3321869.
    102. Murphy WJ, Parham P, Miller JS. NK cells--from bench to clinic. Biol Blood Marrow Transplant. 2012 Jan; 18(1 Suppl):S2-7. PMID: 22226108; PMCID: PMC3260456.
    103. Sun K, Alvarez M, Ames E, Barao I, Chen M, Longo DL, Redelman D, Murphy WJ. Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing. Blood. 2012 Feb 09; 119(6):1590-8. PMID: 22184406; PMCID: PMC3286220.
    104. Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, Carson WE, Chang AE, Characiejus D, Choudhury AR, Coukos G, de Gruijl T, Dillman RO, Dolstra H, Dranoff G, Durrant LG, Finke JH, Galon J, Gollob JA, Gouttefangeas C, Grizzi F, Guida M, Håkansson L, Hege K, Herberman RB, Hodi FS, Hoos A, Huber C, Hwu P, Imai K, Jaffee EM, Janetzki S, June CH, Kalinski P, Kaufman HL, Kawakami K, Kawakami Y, Keilholtz U, Khleif SN, Kiessling R, Kotlan B, Kroemer G, Lapointe R, Levitsky HI, Lotze MT, Maccalli C, Maio M, Marschner JP, Mastrangelo MJ, Masucci G, Melero I, Melief C, Murphy WJ, Nelson B, Nicolini A, Nishimura MI, Odunsi K, Ohashi PS, O'Donnell-Tormey J, Old LJ, Ottensmeier C, Papamichail M, Parmiani G, Pawelec G, Proietti E, Qin S, Rees R, Ribas A, Ridolfi R, Ritter G, Rivoltini L, Romero PJ, Salem ML, Scheper RJ, Seliger B, Sharma P, Shiku H, Singh-Jasuja H, Song W, Straten PT, Tahara H, Tian Z, van Der Burg SH, von Hoegen P, Wang E, Welters MJ, Winter H, Withington T, Wolchok JD, Xiao W, Zitvogel L, Zwierzina H, Marincola FM, Gajewski TF, Wigginton JM, Disis ML. Defining the critical hurdles in cancer immunotherapy. J Transl Med. 2011 Dec 14; 9:214. PMID: 22168571.
      View in: PubMed
    105. Ames E, Harouna S, Meyer C, Welniak LA, Murphy WJ. The triterpenoid CDDO-Me promotes hematopoietic progenitor expansion and myelopoiesis in mice. Biol Blood Marrow Transplant. 2012 Mar; 18(3):396-405. PMID: 22100978; PMCID: PMC3502000.
    106. Srinivasan M, Flynn R, Price A, Ranger A, Browning JL, Taylor PA, Ritz J, Antin JH, Murphy WJ, Luznik L, Shlomchik MJ, Panoskaltsis-Mortari A, Blazar BR. Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans. Blood. 2012 Feb 09; 119(6):1570-80. PMID: 22072556.
      View in: PubMed
    107. Tietze JK, Sckisel GD, Hsiao HH, Murphy WJ. Antigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy? Int Rev Immunol. 2011 Oct-Dec; 30(5-6):238-93. PMID: 22053969.
      View in: PubMed
    108. Barao I, Alvarez M, Redelman D, Weiss JM, Ortaldo JR, Wiltrout RH, Murphy WJ. Hydrodynamic delivery of human IL-15 cDNA increases murine natural killer cell recovery after syngeneic bone marrow transplantation. Biol Blood Marrow Transplant. 2011 Dec; 17(12):1754-64. PMID: 21906575.
      View in: PubMed
    109. Barao I, Alvarez M, Ames E, Orr MT, Stefanski HE, Blazar BR, Lanier LL, Anderson SK, Redelman D, Murphy WJ. Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC. Blood. 2011 Jun 30; 117(26):7032-41. PMID: 21498673.
      View in: PubMed
    110. Zhou Q, Munger ME, Veenstra RG, Weigel BJ, Hirashima M, Munn DH, Murphy WJ, Azuma M, Anderson AC, Kuchroo VK, Blazar BR. Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Blood. 2011 Apr 28; 117(17):4501-10. PMID: 21385853.
      View in: PubMed
    111. Coghill JM, Sarantopoulos S, Moran TP, Murphy WJ, Blazar BR, Serody JS. Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. Blood. 2011 Mar 24; 117(12):3268-76. PMID: 21245483.
      View in: PubMed
    112. Hoffman HJ, Dobie RA, Ko CW, Themann CL, Murphy WJ. Americans hear as well or better today compared with 40 years ago: hearing threshold levels in the unscreened adult population of the United States, 1959-1962 and 1999-2004. Ear Hear. 2010 Dec; 31(6):725-34. PMID: 20683190.
      View in: PubMed
    113. Weiss JM, Ridnour LA, Back T, Hussain SP, He P, Maciag AE, Keefer LK, Murphy WJ, Harris CC, Wink DA, Wiltrout RH. Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy. J Exp Med. 2010 Oct 25; 207(11):2455-67. PMID: 20921282.
      View in: PubMed
    114. Zhou Q, Munger ME, Highfill SL, Tolar J, Weigel BJ, Riddle M, Sharpe AH, Vallera DA, Azuma M, Levine BL, June CH, Murphy WJ, Munn DH, Blazar BR. Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. Blood. 2010 Oct 07; 116(14):2484-93. PMID: 20570856.
      View in: PubMed
    115. Taub DD, Murphy WJ, Longo DL. Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways. Curr Opin Pharmacol. 2010 Aug; 10(4):408-24. PMID: 20595009.
      View in: PubMed
    116. Bouchlaka MN, Redelman D, Murphy WJ. Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects. Immunotherapy. 2010 May; 2(3):399-418. PMID: 20635904.
      View in: PubMed
    117. Li M, Sun K, Redelman D, Welniak LA, Murphy WJ. The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation. Biol Blood Marrow Transplant. 2010 Jun; 16(6):739-50. PMID: 20338256.
      View in: PubMed
    118. Urbieta M, Barao I, Jones M, Jurecic R, Panoskaltsis-Mortari A, Blazar BR, Murphy WJ, Levy RB. Hematopoietic progenitor cell regulation by CD4+CD25+ T cells. Blood. 2010 Jun 10; 115(23):4934-43. PMID: 20200356.
      View in: PubMed
    119. Hu B, He Y, Wu Y, Bao G, Liu H, Welniak LA, Murphy WJ. Activated allogeneic NK cells as suppressors of alloreactive responses. Biol Blood Marrow Transplant. 2010 Jun; 16(6):772-81. PMID: 20197103.
      View in: PubMed
    120. Orr MT, Murphy WJ, Lanier LL. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol. 2010 Apr; 11(4):321-7. PMID: 20190757.
      View in: PubMed
    121. Miller JS, Warren EH, van den Brink MR, Ritz J, Shlomchik WD, Murphy WJ, Barrett AJ, Kolb HJ, Giralt S, Bishop MR, Blazar BR, Falkenburg JH. NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction. Biol Blood Marrow Transplant. 2010 May; 16(5):565-86. PMID: 20152921.
      View in: PubMed
    122. Alderson KL, Murphy WJ. Antigen specific memory T cells and their putative need for the generation of sustained anti-tumor responses. Adv Exp Med Biol. 2010; 684:155-65. PMID: 20795547.
      View in: PubMed
    123. Murphy WJ, Artz AS, Champlin RE, Koreth J, Longo DL, van den Brink MR. Blood stem cell transplantation in older patients. Biol Blood Marrow Transplant. 2009 Dec; 15(12):1638-9. PMID: 19911448.
      View in: PubMed
    124. Koreth J, Alyea EP, Murphy WJ, Welniak LA. Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review. Biol Blood Marrow Transplant. 2009 Dec; 15(12):1502-12. PMID: 19896073.
      View in: PubMed
    125. Weiss JM, Back TC, Scarzello AJ, Subleski JJ, Hall VL, Stauffer JK, Chen X, Micic D, Alderson K, Murphy WJ, Wiltrout RH. Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment. Proc Natl Acad Sci U S A. 2009 Nov 17; 106(46):19455-60. PMID: 19892741.
      View in: PubMed
    126. Ames E, Hallett WH, Murphy WJ. Sensitization of human breast cancer cells to natural killer cell-mediated cytotoxicity by proteasome inhibition. Clin Exp Immunol. 2009 Mar; 155(3):504-13. PMID: 19220837.
      View in: PubMed
    127. O'Shaughnessy MJ, Vogtenhuber C, Sun K, Sitcheran R, Baldwin AS, Murphy WJ, Dang L, Jaffee B, Palmer E, Serody JS, Blazar BR. Ex vivo inhibition of NF-kappaB signaling in alloreactive T-cells prevents graft-versus-host disease. Am J Transplant. 2009 Mar; 9(3):452-62. PMID: 19260829.
      View in: PubMed
    128. Alderson KL, Murphy WJ. Effects of cancer immunotherapy regimens on primary vs. secondary immune responses and the potential impact on long-term antitumor responses. Adv Exp Med Biol. 2009; 633:81-9. PMID: 19209683.
      View in: PubMed
    129. Davis BW, Raudsepp T, Pearks Wilkerson AJ, Agarwala R, Schäffer AA, Houck M, Chowdhary BP, Murphy WJ. A high-resolution cat radiation hybrid and integrated FISH mapping resource for phylogenomic studies across Felidae. Genomics. 2009 Apr; 93(4):299-304. PMID: 18951970.
      View in: PubMed
    130. Hallett WHD, Ames E, Álvarez M, Barao I, Taylor PA, Blazar BR, Murphy WJ. Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses. Biol Blood Marrow Transplant. 2008 Oct; 14(10):1088-1099. PMID: 18804038.
      View in: PubMed
    131. Li M, Sun K, Welniak LA, Murphy WJ. Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease. Expert Opin Pharmacother. 2008 Sep; 9(13):2305-16. PMID: 18710355.
      View in: PubMed
    132. Taylor PA, Ehrhardt MJ, Lees CJ, Panoskaltsis-Mortari A, Krieg AM, Sharpe AH, Murphy WJ, Serody JS, Hemmi H, Akira S, Levy RB, Blazar BR. TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection. Blood. 2008 Oct 15; 112(8):3508-16. PMID: 18614760.
      View in: PubMed
    133. Puliaev R, Puliaeva I, Welniak LA, Ryan AE, Haas M, Murphy WJ, Via CS. CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus. J Immunol. 2008 Jul 01; 181(1):47-61. PMID: 18566369.
      View in: PubMed
    134. Sun K, Li M, Sayers TJ, Welniak LA, Murphy WJ. Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation. Blood. 2008 Aug 15; 112(4):1522-9. PMID: 18539902.
      View in: PubMed
    135. Shanker A, Brooks AD, Tristan CA, Wine JW, Elliott PJ, Yagita H, Takeda K, Smyth MJ, Murphy WJ, Sayers TJ. Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody. J Natl Cancer Inst. 2008 May 07; 100(9):649-62. PMID: 18445820.
      View in: PubMed
    136. Redelman D, Welniak LA, Taub D, Murphy WJ. Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network. Cell Immunol. 2008 Mar-Apr; 252(1-2):111-21. PMID: 18313040.
      View in: PubMed
    137. Alderson KL, Zhou Q, Berner V, Wilkins DE, Weiss JM, Blazar BR, Welniak LA, Wiltrout RH, Redelman D, Murphy WJ. Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapy. J Immunol. 2008 Mar 01; 180(5):2981-8. PMID: 18292520.
      View in: PubMed
    138. Hallett WH, Ames E, Motarjemi M, Barao I, Shanker A, Tamang DL, Sayers TJ, Hudig D, Murphy WJ. Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition. J Immunol. 2008 Jan 01; 180(1):163-70. PMID: 18097016.
      View in: PubMed
    139. Pontius JU, Mullikin JC, Smith DR, Lindblad-Toh K, Gnerre S, Clamp M, Chang J, Stephens R, Neelam B, Volfovsky N, Schäffer AA, Agarwala R, Narfström K, Murphy WJ, Giger U, Roca AL, Antunes A, Menotti-Raymond M, Yuhki N, Pecon-Slattery J, Johnson WE, Bourque G, Tesler G, O'Brien SJ. Initial sequence and comparative analysis of the cat genome. Genome Res. 2007 Nov; 17(11):1675-89. PMID: 17975172; PMCID: PMC2045150.
    140. Vàzquez-Salat N, Yuhki N, Beck T, O'Brien SJ, Murphy WJ. Gene conversion between mammalian CCR2 and CCR5 chemokine receptor genes: a potential mechanism for receptor dimerization. Genomics. 2007 Aug; 90(2):213-24. PMID: 17544254.
      View in: PubMed
    141. Zhou Q, Gault RA, Kozel TR, Murphy WJ. Protection from direct cerebral cryptococcus infection by interferon-gamma-dependent activation of microglial cells. J Immunol. 2007 May 01; 178(9):5753-61. PMID: 17442959.
      View in: PubMed
    142. Berner V, Liu H, Zhou Q, Alderson KL, Sun K, Weiss JM, Back TC, Longo DL, Blazar BR, Wiltrout RH, Welniak LA, Redelman D, Murphy WJ. IFN-gamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy. Nat Med. 2007 Mar; 13(3):354-60. PMID: 17334371.
      View in: PubMed
    143. Mattingly LH, Gault RA, Murphy WJ. Use of systemic proteasome inhibition as an immune-modulating agent in disease. Endocr Metab Immune Disord Drug Targets. 2007 Mar; 7(1):29-34. PMID: 17346202.
      View in: PubMed
    144. Sun K, Li M, Konopleva M, Konoplev S, Stephens LC, Kornblau SM, Frolova O, Wilkins DE, Ma W, Welniak LA, Andreeff M, Murphy WJ. The synthetic triterpenoid, CDDO, suppresses alloreactive T cell responses and reduces murine early acute graft-versus-host disease mortality. Biol Blood Marrow Transplant. 2007 May; 13(5):521-9. PMID: 17448911.
      View in: PubMed
    145. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol. 2007; 25:139-70. PMID: 17129175.
      View in: PubMed
    146. Wang Z, Murphy WJ. [Relationship between CCR5 and acute graft-versus-host disease in murine bone marrow transplantation]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Oct; 14(5):934-40. PMID: 17096892.
      View in: PubMed
    147. Murphy WJ, Davis B, David VA, Agarwala R, Schäffer AA, Pearks Wilkerson AJ, Neelam B, O'Brien SJ, Menotti-Raymond M. A 1.5-Mb-resolution radiation hybrid map of the cat genome and comparative analysis with the canine and human genomes. Genomics. 2007 Feb; 89(2):189-96. PMID: 16997530.
      View in: PubMed
    148. Hallett WH, Murphy WJ. Positive and negative regulation of Natural Killer cells: therapeutic implications. Semin Cancer Biol. 2006 Oct; 16(5):367-82. PMID: 16934486.
      View in: PubMed
    149. Shorts L, Weiss JM, Lee JK, Welniak LA, Subleski J, Back T, Murphy WJ, Wiltrout RH. Stimulation through CD40 on mouse and human renal cell carcinomas triggers cytokine production, leukocyte recruitment, and antitumor responses that can be independent of host CD40 expression. J Immunol. 2006 Jun 01; 176(11):6543-52. PMID: 16709811.
      View in: PubMed
    150. Zhou Q, Gault RA, Kozel TR, Murphy WJ. Immunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosis. Infect Immun. 2006 Apr; 74(4):2161-8. PMID: 16552046.
      View in: PubMed
    151. Barao I, Hanash AM, Hallett W, Welniak LA, Sun K, Redelman D, Blazar BR, Levy RB, Murphy WJ. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. Proc Natl Acad Sci U S A. 2006 Apr 04; 103(14):5460-5. PMID: 16567639.
      View in: PubMed
    152. Johnson WE, Eizirik E, Pecon-Slattery J, Murphy WJ, Antunes A, Teeling E, O'Brien SJ. The late Miocene radiation of modern Felidae: a genetic assessment. Science. 2006 Jan 06; 311(5757):73-7. PMID: 16400146.
      View in: PubMed
    153. Zhou Q, Murphy WJ. Immune response and immunotherapy to Cryptococcus infections. Immunol Res. 2006; 35(3):191-208. PMID: 17172646.
      View in: PubMed
    154. Brooks AD, Ramirez T, Toh U, Onksen J, Elliott PJ, Murphy WJ, Sayers TJ. The proteasome inhibitor bortezomib (Velcade) sensitizes some human tumor cells to Apo2L/TRAIL-mediated apoptosis. Ann N Y Acad Sci. 2005 Nov; 1059:160-7. PMID: 16382051.
      View in: PubMed
    155. Sayers TJ, Murphy WJ. Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy. Cancer Immunol Immunother. 2006 Jan; 55(1):76-84. PMID: 15864587.
      View in: PubMed
    156. Lee JK, Seki N, Sayers TJ, Subleski J, Gruys EM, Murphy WJ, Wiltrout RH. Constitutive expression of functional CD40 on mouse renal cancer cells: induction of Fas and Fas-mediated killing by CD40L. Cell Immunol. 2005 Jun; 235(2):145-52. PMID: 16213477.
      View in: PubMed
    157. Murphy WJ, Agarwala R, Schäffer AA, Stephens R, Smith C, Crumpler NJ, David VA, O'Brien SJ. A rhesus macaque radiation hybrid map and comparative analysis with the human genome. Genomics. 2005 Oct; 86(4):383-95. PMID: 16039092.
      View in: PubMed
    158. Blazar BR, Murphy WJ. Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). Philos Trans R Soc Lond B Biol Sci. 2005 Sep 29; 360(1461):1747-67. PMID: 16147539.
      View in: PubMed
    159. Welniak LA, Kuprash DV, Tumanov AV, Panoskaltsis-Mortari A, Blazar BR, Sun K, Nedospasov SA, Murphy WJ. Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation. Blood. 2006 Jan 01; 107(1):410-2. PMID: 16160014.
      View in: PubMed
    160. Ortaldo JR, Winkler-Pickett RT, Bere EW, Watanabe M, Murphy WJ, Wiltrout RH. In vivo hydrodynamic delivery of cDNA encoding IL-2: rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells. J Immunol. 2005 Jul 15; 175(2):693-9. PMID: 16002664.
      View in: PubMed
    161. Sun K, Wilkins DE, Anver MR, Sayers TJ, Panoskaltsis-Mortari A, Blazar BR, Welniak LA, Murphy WJ. Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity. Blood. 2005 Nov 01; 106(9):3293-9. PMID: 15961519.
      View in: PubMed
    162. Kuprash DV, Tumanov AV, Liepinsh DJ, Koroleva EP, Drutskaya MS, Kruglov AA, Shakhov AN, Southon E, Murphy WJ, Tessarollo L, Grivennikov SI, Nedospasov SA. Novel tumor necrosis factor-knockout mice that lack Peyer's patches. Eur J Immunol. 2005 May; 35(5):1592-600. PMID: 15832287.
      View in: PubMed
    163. Koh CY, Welniak LA, Murphy WJ. Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation: effects of marrow dose. Biol Blood Marrow Transplant. 2005 Apr; 11(4):252-9. PMID: 15812390.
      View in: PubMed
    164. Roca AL, Nash WG, Menninger JC, Murphy WJ, O'Brien SJ. Insertional polymorphisms of endogenous feline leukemia viruses. J Virol. 2005 Apr; 79(7):3979-86. PMID: 15767400.
      View in: PubMed
    165. Zhang YH, Murphy WJ, Russell SW, Morrison DC, Koide N, Yoshida T, Yokochi T. Serum-dependent potentiation of lipopolysaccharide-induced nitric oxide production is mediated by the events after the transcription of inducible type of nitric oxide synthase. Cell Immunol. 2005 Mar; 234(1):16-22. PMID: 15936007.
      View in: PubMed
    166. Teeling EC, Springer MS, Madsen O, Bates P, O'brien SJ, Murphy WJ. A molecular phylogeny for bats illuminates biogeography and the fossil record. Science. 2005 Jan 28; 307(5709):580-4. PMID: 15681385.
      View in: PubMed
    167. Beck TW, Menninger J, Murphy WJ, Nash WG, O'brien SJ, Yuhki N. The feline major histocompatibility complex is rearranged by an inversion with a breakpoint in the distal class I region. Immunogenetics. 2005 Jan; 56(10):702-9. PMID: 15592824.
      View in: PubMed
    168. Murphy WJ, Pevzner PA, O'Brien SJ. Mammalian phylogenomics comes of age. Trends Genet. 2004 Dec; 20(12):631-9. PMID: 15522459.
      View in: PubMed
    169. Gendelman M, Halligan N, Komorowski R, Logan B, Murphy WJ, Blazar BR, Pritchard KA, Drobyski WR. Alpha phenyl-tert-butyl nitrone (PBN) protects syngeneic marrow transplant recipients from the lethal cytokine syndrome occurring after agonistic CD40 antibody administration. Blood. 2005 Jan 01; 105(1):428-31. PMID: 15331451.
      View in: PubMed
    170. Welniak LA, Shorts L, Subleski J, Blazar BR, Wiltrout RH, Murphy WJ. Tumor regression by anti-CD40 and interleukin-2: role of CD40 in hematopoietic cells and organ-specific effects. Biol Blood Marrow Transplant. 2004 Aug; 10(8):534-9. PMID: 15282531.
      View in: PubMed
    171. Roca AL, Bar-Gal GK, Eizirik E, Helgen KM, Maria R, Springer MS, O'Brien SJ, Murphy WJ. Mesozoic origin for West Indian insectivores. Nature. 2004 Jun 10; 429(6992):649-51. PMID: 15190349.
      View in: PubMed
    172. Sun K, Welniak LA, Panoskaltsis-Mortari A, O'Shaughnessy MJ, Liu H, Barao I, Riordan W, Sitcheran R, Wysocki C, Serody JS, Blazar BR, Sayers TJ, Murphy WJ. Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib. Proc Natl Acad Sci U S A. 2004 May 25; 101(21):8120-5. PMID: 15148407.
      View in: PubMed
    173. Kozel TR, Murphy WJ, Brandt S, Blazar BR, Lovchik JA, Thorkildson P, Percival A, Lyons CR. mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. Proc Natl Acad Sci U S A. 2004 Apr 06; 101(14):5042-7. PMID: 15051894.
      View in: PubMed
    174. Welniak LA, Wang Z, Sun K, Kuziel W, Anver MR, Blazar BR, Murphy WJ. An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease. Exp Hematol. 2004 Mar; 32(3):318-24. PMID: 15003318.
      View in: PubMed
    175. Hallett WH, Murphy WJ. Natural killer cells: biology and clinical use in cancer therapy. Cell Mol Immunol. 2004 Feb; 1(1):12-21. PMID: 16212916.
      View in: PubMed
    176. Ortaldo JR, Young HA, Winkler-Pickett RT, Bere EW, Murphy WJ, Wiltrout RH. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides. J Immunol. 2004 Jan 15; 172(2):943-53. PMID: 14707067.
      View in: PubMed
    177. Welniak LA, Karas M, Yakar S, Anver MR, Murphy WJ, LeRoith D. Effects of organ-specific loss of insulin-like growth factor-I production on murine hematopoiesis. Biol Blood Marrow Transplant. 2004 Jan; 10(1):32-9. PMID: 14752777.
      View in: PubMed
    178. Barao I, Murphy WJ. The immunobiology of natural killer cells and bone marrow allograft rejection. Biol Blood Marrow Transplant. 2003 Dec; 9(12):727-41. PMID: 14677112.
      View in: PubMed
    179. Murphy WJ, Bourque G, Tesler G, Pevzner P, O'Brien SJ. Reconstructing the genomic architecture of mammalian ancestors using multispecies comparative maps. Hum Genomics. 2003 Nov; 1(1):30-40. PMID: 15601531; PMCID: PMC3525001.
    180. Dorshkind K, Welniak L, Gault RA, Hixon J, Montecino-Rodriguez E, Horseman ND, Gertner JM, Murphy WJ. Effects of housing on the thymic deficiency in dwarf mice and its reversal by growth hormone administration. Clin Immunol. 2003 Nov; 109(2):197-202. PMID: 14597218.
      View in: PubMed
    181. O'Brien SJ, Murphy WJ. Genomics. A dog's breakfast? Science. 2003 Sep 26; 301(5641):1854-5. PMID: 14512608.
      View in: PubMed
    182. Teeling EC, Madsen O, Murphy WJ, Springer MS, O'Brien SJ. Nuclear gene sequences confirm an ancient link between New Zealand's short-tailed bat and South American noctilionoid bats. Mol Phylogenet Evol. 2003 Aug; 28(2):308-19. PMID: 12878467.
      View in: PubMed
    183. Koh CY, Ortaldo JR, Blazar BR, Bennett M, Murphy WJ. NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade. Blood. 2003 Dec 01; 102(12):4067-75. PMID: 12893752.
      View in: PubMed
    184. Murphy WJ, Frönicke L, O'Brien SJ, Stanyon R. The origin of human chromosome 1 and its homologs in placental mammals. Genome Res. 2003 Aug; 13(8):1880-8. PMID: 12869576.
      View in: PubMed
    185. Sun R, Gault RA, Welniak LA, Tian ZG, Richards S, Murphy WJ. Immunologic and hematopoietic effects of recombinant human prolactin after syngeneic bone marrow transplantation in mice. Biol Blood Marrow Transplant. 2003 Jul; 9(7):426-34. PMID: 12869956.
      View in: PubMed
    186. Salcedo R, Zhang X, Young HA, Michael N, Wasserman K, Ma WH, Martins-Green M, Murphy WJ, Oppenheim JJ. Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells. Blood. 2003 Sep 15; 102(6):1966-77. PMID: 12791666.
      View in: PubMed
    187. Sayers TJ, Brooks AD, Koh CY, Ma W, Seki N, Raziuddin A, Blazar BR, Zhang X, Elliott PJ, Murphy WJ. The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP. Blood. 2003 Jul 01; 102(1):303-10. PMID: 12637321.
      View in: PubMed
    188. Murphy WJ, Welniak L, Back T, Hixon J, Subleski J, Seki N, Wigginton JM, Wilson SE, Blazar BR, Malyguine AM, Sayers TJ, Wiltrout RH. Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: coordination of dendritic and CD8+ cell responses. J Immunol. 2003 Mar 01; 170(5):2727-33. PMID: 12594303.
      View in: PubMed
    189. Chen ZM, O'Shaughnessy MJ, Gramaglia I, Panoskaltsis-Mortari A, Murphy WJ, Narula S, Roncarolo MG, Blazar BR. IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function. Blood. 2003 Jun 15; 101(12):5076-83. PMID: 12609834.
      View in: PubMed
    190. Raziuddin A, Longo DL, Bennett M, Winkler-Pickett R, Ortaldo JR, Murphy WJ. Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens. Blood. 2002 Oct 15; 100(8):3026-33. PMID: 12351417.
      View in: PubMed
    191. Salcedo R, Martins-Green M, Gertz B, Oppenheim JJ, Murphy WJ. Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts. Clin Cancer Res. 2002 Aug; 8(8):2655-65. PMID: 12171898.
      View in: PubMed
    192. Szocinski JL, Khaled AR, Hixon J, Halverson D, Funakoshi S, Fanslow WC, Boyd A, Taub DD, Durum SK, Siegall CB, Longo DL, Murphy WJ. Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax. Blood. 2002 Jul 01; 100(1):217-23. PMID: 12070030.
      View in: PubMed
    193. O'Brien SJ, Menotti-Raymond M, Murphy WJ, Yuhki N. The Feline Genome Project. Annu Rev Genet. 2002; 36:657-86. PMID: 12359739.
      View in: PubMed
    194. Davis RR, Murphy WJ, Snawder JE, Striley CA, Henderson D, Khan A, Krieg EF. Susceptibility to the ototoxic properties of toluene is species specific. Hear Res. 2002 Apr; 166(1-2):24-32. PMID: 12062755.
      View in: PubMed
    195. Crespo A, Filla MB, Murphy WJ. Low responsiveness to IFN-gamma, after pretreatment of mouse macrophages with lipopolysaccharides, develops via diverse regulatory pathways. Eur J Immunol. 2002 03; 32(3):710-9. PMID: 11870615.
      View in: PubMed
    196. Welniak LA, Sun R, Murphy WJ. The role of growth hormone in T-cell development and reconstitution. J Leukoc Biol. 2002 Mar; 71(3):381-7. PMID: 11867675.
      View in: PubMed
    197. Kadereit S, Deeds LS, Haynesworth SE, Koc ON, Kozik MM, Szekely E, Daum-Woods K, Goetchius GW, Fu P, Welniak LA, Murphy WJ, Laughlin MJ. Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layer. Stem Cells. 2002; 20(6):573-82. PMID: 12456965.
      View in: PubMed
    198. Cui YH, Le Y, Gong W, Proost P, Van Damme J, Murphy WJ, Wang JM. Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J Immunol. 2002 Jan 01; 168(1):434-42. PMID: 11751990.
      View in: PubMed
    199. Hixon JA, Anver MR, Blazar BR, Panoskaltsis-Mortari A, Wiltrout RH, Murphy WJ. Administration of either anti-CD40 or interleukin-12 following lethal total body irradiation induces acute lethal toxicity affecting the gut. Biol Blood Marrow Transplant. 2002; 8(6):316-25. PMID: 12108917.
      View in: PubMed
    200. Koh CY, Raziuddin A, Welniak LA, Blazar BR, Bennett M, Murphy WJ. NK inhibitory-receptor blockade for purging of leukemia: effects on hematopoietic reconstitution. Biol Blood Marrow Transplant. 2002; 8(1):17-25. PMID: 11846352.
      View in: PubMed
    201. Schneider GP, Salcedo R, Welniak LA, Howard OM, Murphy WJ. The diverse role of chemokines in tumor progression: prospects for intervention (Review). Int J Mol Med. 2001 Sep; 8(3):235-44. PMID: 11494048.
      View in: PubMed
    202. Salcedo R, Young HA, Ponce ML, Ward JM, Kleinman HK, Murphy WJ, Oppenheim JJ. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J Immunol. 2001 Jun 15; 166(12):7571-8. PMID: 11390513.
      View in: PubMed
    203. Murphy WJ, Koh CY, Raziuddin A, Bennett M, Longo DL. Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies. Immunol Rev. 2001 Jun; 181:279-89. PMID: 11513149.
      View in: PubMed
    204. Koh CY, Blazar BR, George T, Welniak LA, Capitini CM, Raziuddin A, Murphy WJ, Bennett M. Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. Blood. 2001 May 15; 97(10):3132-7. PMID: 11342440.
      View in: PubMed
    205. Tani K, Murphy WJ, Chertov O, Oppenheim JJ, Wang JM. The neutrophil granule protein cathepsin G activates murine T lymphocytes and upregulates antigen-specific IG production in mice. Biochem Biophys Res Commun. 2001 Apr 13; 282(4):971-6. PMID: 11352647.
      View in: PubMed
    206. Welniak LA, Khaled AR, Anver MR, Komschlies KL, Wiltrout RH, Durum S, Ruscetti FR, Blazar BR, Murphy WJ. Gastrointestinal cells of IL-7 receptor null mice exhibit increased sensitivity to irradiation. J Immunol. 2001 Mar 01; 166(5):2924-8. PMID: 11207240.
      View in: PubMed
    207. Lee CK, Kim K, Welniak LA, Murphy WJ, Muegge K, Durum SK. Thymic emigrants isolated by a new method possess unique phenotypic and functional properties. Blood. 2001 Mar 01; 97(5):1360-9. PMID: 11222381.
      View in: PubMed
    208. Welniak LA, Blazar BR, Wiltrout RH, Anver MR, Murphy WJ. Role of interleukin-12 in acute graft-versus-host disease(1). Transplant Proc. 2001 Feb-Mar; 33(1-2):1752-3. PMID: 11267498.
      View in: PubMed
    209. Boussiotis VA, Chen ZM, Zeller JC, Murphy WJ, Berezovskaya A, Narula S, Roncarolo MG, Blazar BR. Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease. Blood. 2001 Jan 15; 97(2):565-71. PMID: 11154238.
      View in: PubMed
    210. Hixon JA, Blazar BR, Anver MR, Wiltrout RH, Murphy WJ. Antibodies to CD40 induce a lethal cytokine cascade after syngeneic bone marrow transplantation. Biol Blood Marrow Transplant. 2001; 7(3):136-43. PMID: 11302547.
      View in: PubMed
    211. Welniak LA, Richards SM, Murphy WJ. Effects of prolactin on hematopoiesis. Lupus. 2001; 10(10):700-5. PMID: 11721696.
      View in: PubMed
    212. Famularo G, Di Marzio L, Ulisse S, Cifone MG, De Simone C. Alternative strategies other than growth hormone for the treatment of immune diseases. Trends Immunol. 2001 Jan; 22(1):14-6. PMID: 11334029.
      View in: PubMed
    213. Panoskaltsis-Mortari A, Taylor PA, Rubin JS, Uren A, Welniak LA, Murphy WJ, Farrell CL, Lacey DL, Blazar BR. Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury. Blood. 2000 Dec 15; 96(13):4350-6. PMID: 11110712.
      View in: PubMed
    214. Blazar BR, Lees CJ, Martin PJ, Noelle RJ, Kwon B, Murphy W, Taylor PA. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions. J Immunol. 2000 Nov 01; 165(9):4901-9. PMID: 11046015.
      View in: PubMed
    215. Koh CY, Welniak LA, Murphy WJ. Adoptive cellular immunotherapy: NK cells and bone marrow transplantation. Histol Histopathol. 2000 10; 15(4):1201-10. PMID: 11005245.
      View in: PubMed
    216. Murphy WJ. Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes. J Clin Invest. 2000 Sep; 106(6):745-7. PMID: 10995784.
      View in: PubMed
    217. Richards SM, Murphy WJ. Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function. J Neuroimmunol. 2000 Sep 01; 109(1):56-62. PMID: 10969182.
      View in: PubMed
    218. Panoskaltsis-Mortari A, Strieter RM, Hermanson JR, Fegeding KV, Murphy WJ, Farrell CL, Lacey DL, Blazar BR. Induction of monocyte- and T-cell-attracting chemokines in the lung during the generation of idiopathic pneumonia syndrome following allogeneic murine bone marrow transplantation. Blood. 2000 Aug 01; 96(3):834-9. PMID: 10910893.
      View in: PubMed
    219. Welniak LA, Tian ZG, Sun R, Keller JR, Richards S, Ruscetti FW, Murphy WJ. Effects of growth hormone and prolactin on hematopoiesis. Leuk Lymphoma. 2000 Aug; 38(5-6):435-45. PMID: 10953965.
      View in: PubMed
    220. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood. 2000 Jul 01; 96(1):34-40. PMID: 10891427.
      View in: PubMed
    221. Raziuddin A, Bennett M, Winkler-Pickett R, Ortaldo JR, Longo DL, Murphy WJ. Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts. Blood. 2000 Jun 15; 95(12):3840-4. PMID: 10845918.
      View in: PubMed
    222. Alexandroff AB, Jackson AM, Paterson T, Haley JL, Ross JA, Longo DL, Murphy WJ, James K, Taub DD. Role for CD40-CD40 ligand interactions in the immune response to solid tumours. Mol Immunol. 2000 Jun; 37(9):515-26. PMID: 11163401.
      View in: PubMed
    223. Tani K, Murphy WJ, Chertov O, Salcedo R, Koh CY, Utsunomiya I, Funakoshi S, Asai O, Herrmann SH, Wang JM, Kwak LW, Oppenheim JJ. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int Immunol. 2000 May; 12(5):691-700. PMID: 10784615.
      View in: PubMed
    224. Murphy WJ, Longo DL. Growth hormone as an immunomodulating therapeutic agent. Immunol Today. 2000 May; 21(5):211-3. PMID: 10877541.
      View in: PubMed
    225. Lee-Huang S, Huang PL, Sun Y, Chen HC, Kung HF, Huang PL, Murphy WJ. Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30. Anticancer Res. 2000 Mar-Apr; 20(2A):653-9. PMID: 10810336.
      View in: PubMed
    226. Ziebold JL, Hixon J, Boyd A, Murphy WJ. Differential effects of CD40 stimulation on normal and neoplastic cell growth. Arch Immunol Ther Exp (Warsz). 2000; 48(4):225-33. PMID: 11059638.
      View in: PubMed
    227. Welniak LA, Blazar BR, Anver MR, Wiltrout RH, Murphy WJ. Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning. Biol Blood Marrow Transplant. 2000; 6(6):604-12. PMID: 11128810.
      View in: PubMed
    228. Zeller JC, Panoskaltsis-Mortari A, Murphy WJ, Ruscetti FW, Narula S, Roncarolo MG, Blazar BR. Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. J Immunol. 1999 Oct 01; 163(7):3684-91. PMID: 10490963.
      View in: PubMed
    229. Murphy WJ, Blazar BR. New strategies for preventing graft-versus-host disease. Curr Opin Immunol. 1999 Oct; 11(5):509-15. PMID: 10508701.
      View in: PubMed
    230. Ortaldo JR, Mason AT, Winkler-Pickett R, Raziuddin A, Murphy WJ, Mason LH. Ly-49 receptor expression and functional analysis in multiple mouse strains. J Leukoc Biol. 1999 Sep; 66(3):512-20. PMID: 10496323.
      View in: PubMed
    231. Kirken RA, Erwin RA, Taub D, Murphy WJ, Behbod F, Wang L, Pericle F, Farrar WL. Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells. J Leukoc Biol. 1999 Jun; 65(6):891-9. PMID: 10380915.
      View in: PubMed
    232. Hirano A, Longo DL, Taub DD, Ferris DK, Young LS, Eliopoulos AG, Agathanggelou A, Cullen N, Macartney J, Fanslow WC, Murphy WJ. Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand. Blood. 1999 May 01; 93(9):2999-3007. PMID: 10216096.
      View in: PubMed
    233. Woody MA, Welniak LA, Sun R, Tian ZG, Henry M, Richards S, Raziuddin A, Longo DL, Murphy WJ. Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine. Exp Hematol. 1999 May; 27(5):811-6. PMID: 10340396.
      View in: PubMed
    234. Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol. 1999 Apr; 154(4):1125-35. PMID: 10233851.
      View in: PubMed
    235. Lee CK, Kim K, Geiman TM, Murphy WJ, Muegge K, Durum SK. Cloning thymic precursor cells: demonstration that individual pro-T1 cells have dual T-NK potential and individual pro-T2 cells have dual alphabeta-gammadelta T cell potential. Cell Immunol. 1999 Feb 01; 191(2):139-44. PMID: 9973536.
      View in: PubMed
    236. Wolff EA, Greenfield B, Taub DD, Murphy WJ, Bennett KL, Aruffo A. Generation of artificial proteoglycans containing glycosaminoglycan-modified CD44. Demonstration of the interaction between rantes and chondroitin sulfate. J Biol Chem. 1999 Jan 22; 274(4):2518-24. PMID: 9891023.
      View in: PubMed
    237. Woody MA, Welniak LA, Richards S, Taub DD, Tian Z, Sun R, Longo DL, Murphy WJ. Use of neuroendocrine hormones to promote reconstitution after bone marrow transplantation. Neuroimmunomodulation. 1999 Jan-Apr; 6(1-2):69-80. PMID: 9876237.
      View in: PubMed
    238. Murphy WJ, Funakoshi S, Fanslow WC, Rager HC, Taub DD, Longo DL. CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras. Clin Immunol. 1999 Jan; 90(1):22-7. PMID: 9884349.
      View in: PubMed
    239. Murphy WJ, Welniak LA, Taub DD, Wiltrout RH, Taylor PA, Vallera DA, Kopf M, Young H, Longo DL, Blazar BR. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest. 1998 Nov 01; 102(9):1742-8. PMID: 9802888.
      View in: PubMed
    240. Durum SK, Lee CK, Geiman TM, Murphy WJ, Muegge K. CD16 cross-linking blocks rearrangement of the TCR beta locus and development of alpha beta T cells and induces development of NK cells from thymic progenitors. J Immunol. 1998 Oct 01; 161(7):3325-9. PMID: 9759848.
      View in: PubMed
    241. Spence SE, Keller JR, Ruscetti FW, McCauslin CS, Gooya JM, Funakoshi S, Longo DL, Murphy WJ. Engraftment of ex vivo expanded and cycling human cord blood hematopoietic progenitor cells in SCID mice. Exp Hematol. 1998 Jun; 26(6):507-14. PMID: 9620284.
      View in: PubMed
    242. Nguyen BY, Clerici M, Venzon DJ, Bauza S, Murphy WJ, Longo DL, Baseler M, Gesundheit N, Broder S, Shearer G, Yarchoan R. Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients. AIDS. 1998 May 28; 12(8):895-904. PMID: 9631143.
      View in: PubMed
    243. Contassot E, Murphy W, Angonin R, Pavy JJ, Bittencourt MC, Robinet E, Reynolds CW, Cahn JY, Hervé P, Tiberghien P. In vivo alloreactive potential of ex vivo-expanded primary T lymphocytes. Transplantation. 1998 May 27; 65(10):1365-70. PMID: 9625020.
      View in: PubMed
    244. Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW, Murphy WJ. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest. 1998 May 01; 101(9):1835-42. PMID: 9576746.
      View in: PubMed
    245. Tian ZG, Woody MA, Sun R, Welniak LA, Raziuddin A, Funakoshi S, Tsarfaty G, Longo DL, Murphy WJ. Recombinant human growth hormone promotes hematopoietic reconstitution after syngeneic bone marrow transplantation in mice. Stem Cells. 1998; 16(3):193-9. PMID: 9617894.
      View in: PubMed
    246. Raziuddin A, Longo DL, Mason L, Ortaldo JR, Bennett M, Murphy WJ. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. J Immunol. 1998 Jan 01; 160(1):87-94. PMID: 9551959.
      View in: PubMed
    247. Oppenheim JJ, Murphy WJ, Chertox O, Schirrmacher V, Wang JM. Prospects for cytokine and chemokine biotherapy. Clin Cancer Res. 1997 Dec; 3(12 Pt 2):2682-6. PMID: 10068274.
      View in: PubMed
    248. Funakoshi S, Hirano A, Beckwith M, Asai O, Jorgensen G, Tian Z, Hornick JL, Hu P, Khawli LA, Epstein AL, Longo DL, Murphy WJ. Antitumor effects of nonconjugated murine Lym-2 and human-mouse chimeric CLL-1 monoclonal antibodies against various human lymphoma cell lines in vitro and in vivo. Blood. 1997 Oct 15; 90(8):3160-6. PMID: 9376598.
      View in: PubMed
    249. Chertov O, Ueda H, Xu LL, Tani K, Murphy WJ, Wang JM, Howard OM, Sayers TJ, Oppenheim JJ. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med. 1997 Aug 29; 186(5):739-47. PMID: 9271589.
      View in: PubMed
    250. Murphy WJ, Longo DL. The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation. Immunol Rev. 1997 Jun; 157:167-76. PMID: 9255629.
      View in: PubMed
    251. Taub DD, Murphy WJ, Asai O, Fenton RG, Peltz G, Key ML, Turcovski-Corrales S, Longo DL. Induction of alloantigen-specific T cell tolerance through the treatment of human T lymphocytes with wortmannin. J Immunol. 1997 Mar 15; 158(6):2745-55. PMID: 9058809.
      View in: PubMed
    252. Funakoshi S, Taub DD, Anver MR, Raziuddin A, Asai O, Reddy V, Rager H, Fanslow WC, Longo DL, Murphy WJ. Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice. J Clin Invest. 1997 Feb 01; 99(3):484-91. PMID: 9022082.
      View in: PubMed
    253. Funakoshi S, Taub DD, Asai O, Hirano A, Ruscetti FW, Longo DL, Murphy WJ. Effects of CD40 stimulation in the prevention of human EBV-lymphomagenesis. Leuk Lymphoma. 1997 Jan; 24(3-4):187-99. PMID: 9156649.
      View in: PubMed
    254. Taub DD, Key ML, Longo DL, Murphy WJ. Chemokine-induced human lymphocyte infiltration and engraftment in huPBL-SCID mice. Methods Enzymol. 1997; 287:265-91. PMID: 9330328.
      View in: PubMed
    255. Raziuddin A, Longo DL, Mason L, Ortaldo JR, Murphy WJ. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice. Int Immunol. 1996 Dec; 8(12):1833-9. PMID: 8982767.
      View in: PubMed
    256. Conlon KC, Anver MR, Longo DL, Ortaldo JR, Murphy WJ. Adoptive immunotherapy involving recombinant human M-CSF and R24 anti-melanoma antibody induces human T-cell infiltration into human melanoma xenografts. J Immunother Emphasis Tumor Immunol. 1996 Sep; 19(5):317-23. PMID: 8941871.
      View in: PubMed
    257. Murphy WJ, Taub DD, Longo DL. The huPBL-SCID mouse as a means to examine human immune function in vivo. Semin Immunol. 1996 Aug; 8(4):233-41. PMID: 8883146.
      View in: PubMed
    258. Taub DD, Anver M, Oppenheim JJ, Longo DL, Murphy WJ. T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J Clin Invest. 1996 Apr 15; 97(8):1931-41. PMID: 8621778.
      View in: PubMed
    259. Schwarzenberger P, Spence S, Lohrey N, Kmiecik T, Longo DL, Murphy WJ, Ruscetti FW, Keller JR. Gene transfer of multidrug resistance into a factor-dependent human hematopoietic progenitor cell line: in vivo model for genetically transferred chemoprotection. Blood. 1996 Apr 01; 87(7):2723-31. PMID: 8639888.
      View in: PubMed
    260. Taub DD, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J Immunol. 1996 Mar 15; 156(6):2095-2103. PMID: 8690897.
      View in: PubMed
    261. Murphy WJ, Tian ZG, Asai O, Funakoshi S, Rotter P, Henry M, Strieter RM, Kunkel SL, Longo DL, Taub DD. Chemokines and T lymphocyte activation: II. Facilitation of human T cell trafficking in severe combined immunodeficiency mice. J Immunol. 1996 Mar 15; 156(6):2104-11. PMID: 8690898.
      View in: PubMed
    262. Funakoshi S, Longo DL, Murphy WJ. Differential in vitro and in vivo antitumor effects mediated by anti-CD40 and anti-CD20 monoclonal antibodies against human B-cell lymphomas. J Immunother Emphasis Tumor Immunol. 1996 Mar; 19(2):93-101. PMID: 8732692.
      View in: PubMed
    263. Taub DD, Longo DL, Murphy WJ. Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice. Blood. 1996 Feb 15; 87(4):1423-31. PMID: 8608232.
      View in: PubMed
    264. Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, Longo DL, Taub DD, Oppenheim JJ. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem. 1996 Feb 09; 271(6):2935-40. PMID: 8621683.
      View in: PubMed
    265. Taub DD, Ortaldo JR, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol. 1996 Jan; 59(1):81-9. PMID: 8558072.
      View in: PubMed
    266. Tian ZG, Longo DL, Funakoshi S, Asai O, Ferris DK, Widmer M, Murphy WJ. In vivo antitumor effects of unconjugated CD30 monoclonal antibodies on human anaplastic large-cell lymphoma xenografts. Cancer Res. 1995 Nov 15; 55(22):5335-41. PMID: 7585597.
      View in: PubMed
    267. Spence SE, Keller JR, Ruscetti FW, Czarra KT, Gooya JM, Funakoshi S, Longo DL, Murphy WJ. Engraftment of SCID mice by human bone marrow hematopoietic cells cultured in vitro: an in vivo model for human gene transfer. Leukemia. 1995 Oct; 9 Suppl 1:S43-7. PMID: 7475312.
      View in: PubMed
    268. Murphy WJ, Raziuddin A, Mason L, Kumar V, Bennett M, Longo DL. NK cell subsets in the regulation of murine hematopoiesis. I. 5E6+ NK cells promote hematopoietic growth in H-2d strain mice. J Immunol. 1995 Sep 15; 155(6):2911-7. PMID: 7673708.
      View in: PubMed
    269. Murphy WJ, Funakoshi S, Beckwith M, Rushing SE, Conley DK, Armitage RJ, Fanslow WC, Rager HC, Taub DD, Ruscetti FW. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes. Blood. 1995 Sep 01; 86(5):1946-53. PMID: 7544649.
      View in: PubMed
    270. Xu L, Badolato R, Murphy WJ, Longo DL, Anver M, Hale S, Oppenheim JJ, Wang JM. A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion. J Immunol. 1995 Aug 01; 155(3):1184-90. PMID: 7636186.
      View in: PubMed
    271. Turley JM, Funakoshi S, Ruscetti FW, Kasper J, Murphy WJ, Longo DL, Birchenall-Roberts MC. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta. Cell Growth Differ. 1995 Jun; 6(6):655-63. PMID: 7669719.
      View in: PubMed
    272. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, Oppenheim JJ. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest. 1995 Mar; 95(3):1370-6. PMID: 7883984.
      View in: PubMed
    273. Wiltrout RH, Gregorio TA, Fenton RG, Longo DL, Ghosh P, Murphy WJ, Komschlies KL. Cellular and molecular studies in the treatment of murine renal cancer. Semin Oncol. 1995 Feb; 22(1):9-16. PMID: 7855624.
      View in: PubMed
    274. Funakoshi S, Beckwith M, Fanslow W, Longo DL, Murphy WJ. Epstein-Barr virus-induced human B-cell lymphoma arising in HuPBL-SCID chimeric mice: characterization and the role of CD40 stimulation in their treatment and prevention. Pathobiology. 1995; 63(3):133-42. PMID: 8821629.
      View in: PubMed
    275. Murphy WJ, Rui H, Longo DL. Effects of growth hormone and prolactin immune development and function. Life Sci. 1995; 57(1):1-14. PMID: 7596216.
      View in: PubMed
    276. Tsarfaty G, Longo DL, Murphy WJ. Human insulin-like growth factor I exerts hematopoietic growth-promoting effects after in vivo administration. Exp Hematol. 1994 Dec; 22(13):1273-7. PMID: 7957713.
      View in: PubMed
    277. Tiberghien P, Reynolds CW, Keller J, Spence S, Deschaseaux M, Certoux JM, Contassot E, Murphy WJ, Lyons R, Chiang Y. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood. 1994 Aug 15; 84(4):1333-41. PMID: 8049449.
      View in: PubMed
    278. Murphy WJ, Durum SK, Anver MR, Ferris DK, McVicar DW, O'Shea JJ, Ruscetti SK, Smith MR, Young HA, Longo DL. Induction of T cell differentiation and lymphomagenesis in the thymus of mice with severe combined immune deficiency (SCID). J Immunol. 1994 Aug 01; 153(3):1004-14. PMID: 7913108.
      View in: PubMed
    279. Murphy WJ, Taub DD, Anver M, Conlon K, Oppenheim JJ, Kelvin DJ, Longo DL. Human RANTES induces the migration of human T lymphocytes into the peripheral tissues of mice with severe combined immune deficiency. Eur J Immunol. 1994 Aug; 24(8):1823-7. PMID: 7519996.
      View in: PubMed
    280. Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, Kelvin DJ, Oppenheim JJ. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med. 1994 Jul 01; 180(1):203-9. PMID: 7516407.
      View in: PubMed
    281. Taub DD, Tsarfaty G, Lloyd AR, Durum SK, Longo DL, Murphy WJ. Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment. J Clin Invest. 1994 Jul; 94(1):293-300. PMID: 7518833.
      View in: PubMed
    282. Funakoshi S, Longo DL, Beckwith M, Conley DK, Tsarfaty G, Tsarfaty I, Armitage RJ, Fanslow WC, Spriggs MK, Murphy WJ. Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood. 1994 May 15; 83(10):2787-94. PMID: 7514045.
      View in: PubMed
    283. Siefer AK, Longo DL, Harrison CL, Reynolds CW, Murphy WJ. Activated natural killer cells and interleukin-2 promote granulocytic and megakaryocytic reconstitution after syngeneic bone marrow transplantation in mice. Blood. 1993 Oct 15; 82(8):2577-84. PMID: 8400305.
      View in: PubMed
    284. Murphy WJ, Back TC, Conlon KC, Komschlies KL, Ortaldo JR, Sayers TJ, Wiltrout RH, Longo DL. Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts. J Clin Invest. 1993 Oct; 92(4):1918-24. PMID: 8408644.
      View in: PubMed
    285. Murphy WJ, Reynolds CW, Tiberghien P, Longo DL. Natural killer cells and bone marrow transplantation. J Natl Cancer Inst. 1993 Sep 15; 85(18):1475-82. PMID: 8360930.
      View in: PubMed
    286. Murphy WJ, Durum SK, Longo DL. Differential effects of growth hormone and prolactin on murine T cell development and function. J Exp Med. 1993 Jul 01; 178(1):231-6. PMID: 8315380.
      View in: PubMed
    287. Murphy WJ, Conlon KC, Sayers TJ, Wiltrout RH, Back TC, Ortaldo JR, Longo DL. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency. J Immunol. 1993 Apr 15; 150(8 Pt 1):3634-42. PMID: 8468492.
      View in: PubMed
    288. Murphy WJ, Durum SK, Longo DL. Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo. J Immunol. 1992 Dec 15; 149(12):3851-7. PMID: 1460277.
      View in: PubMed
    289. Murphy WJ, Durum SK, Anver M, Frazier M, Longo DL. Recombinant human growth hormone promotes human lymphocyte engraftment in immunodeficient mice and results in an increased incidence of human Epstein Barr virus-induced B-cell lymphoma. Brain Behav Immun. 1992 Dec; 6(4):355-64. PMID: 1336993.
      View in: PubMed
    290. Murphy WJ, Tsarfaty G, Longo DL. Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidine. Blood. 1992 Sep 15; 80(6):1443-7. PMID: 1520871.
      View in: PubMed
    291. Murphy WJ, Longo DL. Hematopoietic growth-promoting effects of natural killer cells in mice in response to in vivo administration of human interleukin-2. J Natl Cancer Inst. 1992 Aug 05; 84(15):1195-200. PMID: 1635088.
      View in: PubMed
    292. Murphy WJ, Keller JR, Harrison CL, Young HA, Longo DL. Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo. Blood. 1992 Aug 01; 80(3):670-7. PMID: 1379086.
      View in: PubMed
    293. Murphy WJ, Durum SK, Anver MR, Longo DL. Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. J Immunol. 1992 Jun 15; 148(12):3799-805. PMID: 1602129.
      View in: PubMed
    294. Murphy WJ, Bennett M, Anver MR, Baseler M, Longo DL. Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions. Eur J Immunol. 1992 Jun; 22(6):1421-7. PMID: 1534757.
      View in: PubMed
    295. Murphy WJ, Durum SK, Longo DL. Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice. Proc Natl Acad Sci U S A. 1992 May 15; 89(10):4481-5. PMID: 1584780.
      View in: PubMed
    296. Murphy WJ, Bennett M, Kumar V, Longo DL. Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation. J Immunol. 1992 May 01; 148(9):2953-60. PMID: 1573278.
      View in: PubMed
    297. Kozel TR, Wilson MA, Murphy JW. Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans. Infect Immun. 1991 Sep; 59(9):3101-10. PMID: 1831795.
      View in: PubMed
    298. Murphy WJ, Kumar V, Bennett M. Natural killer cells activated with interleukin 2 in vitro can be adoptively transferred and mediate hematopoietic histocompatibility-1 antigen-specific bone marrow rejection in vivo. Eur J Immunol. 1990 Aug; 20(8):1729-34. PMID: 2209686.
      View in: PubMed
    299. Murphy WJ, Kumar V, Cope JC, Bennett M. An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells. J Immunol. 1990 May 01; 144(9):3305-11. PMID: 2329274.
      View in: PubMed
    300. Murphy WJ, Kumar V, Bennett M. Immunobiology of bone marrow transplantation: studies using scid mice. Curr Top Microbiol Immunol. 1989; 152:251-8. PMID: 2805793.
      View in: PubMed
    301. Bennett M, Kumar V, Mikhael A, Murphy WJ, Rembecki RM, Sentman CL, David CS. Rejection of bone marrow cells by irradiated mice: NK and T cells recognize different antigens. Transplant Proc. 1987 Dec; 19(6 Suppl 7):5-11. PMID: 3321646.
      View in: PubMed
    302. Murphy WJ, Kumar V, Bennett M. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J Exp Med. 1987 Nov 01; 166(5):1499-509. PMID: 3316472.
      View in: PubMed
    303. Murphy WJ, Kumar V, Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med. 1987 Apr 01; 165(4):1212-7. PMID: 3549961.
      View in: PubMed